Conflicting judicial opinions over the FDA’s approval of mifepristone underscore the escalating chaos over abortion in the months since SCOTUS overturned Roe v. Wade, says Dean Rachel Rebouche.
Conflicting judicial opinions over the FDA’s approval of mifepristone underscore the escalating chaos over abortion in the months since SCOTUS overturned Roe v. Wade, says Dean Rachel Rebouche.